Reduced hypoxic burden following carbonic anhydrase inhibition in obstructive sleep apnea – a randomized placebo-controlled study

C. Strassberger (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), K. Stenlöf (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden), D. Zou (Gothenburg, Sweden)

Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Session: Advances in therapeutic plans for sleep disordered breathing
Session type: E-poster
Number: 747

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Strassberger (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), K. Stenlöf (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden), D. Zou (Gothenburg, Sweden). Reduced hypoxic burden following carbonic anhydrase inhibition in obstructive sleep apnea – a randomized placebo-controlled study. 747

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A randomized, cross-over, placebo-controlled study of the effects of CPAP upon oxidative stress and nitrate deficiency in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014



Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018
Year: 2018



The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Year: 2019



Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021
Year: 2021



Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial
Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019
Year: 2020



Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Source: Eur Respir J, 52 (1) 1800149; 10.1183/13993003.00149-2018
Year: 2018



Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013

A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019